Received Nov 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | OT |
small red dots on his chest/belly; Initial information received on 28-Oct-2025 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (healthcare professional). This case involves a 15 years old male patient who experienced small red dots on his chest/belly after receiving Influenza Trivalent Recombinant Vaccine [FLUBLOK TIV]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 25-Oct-2025, the patient received an unknown dose of suspect Influenza Trivalent Recombinant Vaccine (lot number, strength, expiry date and formulation-unknown) via unknown route in unknown administration site for Prophylactic vaccination (Immunisation). Information on the batch number was requested corresponding to the one at time of event occurrence. On 26-Oct-2025 the patient developed a non-serious small red dots on his chest/belly (erythema) (latency-1 day). Action taken was not applicable. The patient was treated with Diphenhydramine Hydrochloride (Benadryl) At time of reporting, the outcome was Unknown for the event.